We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. DermTech’s GEP-2 assay test is a noninvasive way to ...
“GEP testing provides significant value for clinicians and patients, and that’s exactly what we saw in our study. This molecular test provides an objective data point that can help improve definitive ...
Merlin CP-GEP is the only molecular test recognized by NCCN as predictive and appropriate for use in select T1 and T2 patients to support shared decision-making regarding Sentinel Lymph Node Biopsy.
Please provide your email address to receive an email when new articles are posted on . Dermatologists should consider ordering a 31-gene expression profile test to determine metastasis risk in ...
SkylineDx said it published new peer-reviewed data where its Merlin CP-GEP Test outperforms the competition and current standards of care for identifying melanoma risk using molecular testing. In ...
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will present new data across its dermatologic ...
Medicare-eligible patients with cutaneous squamous cell carcinoma (cSCC) could save on health care costs by utilizing the 40-gene expression profile (40-GEP) to guide treatment decisions. Patients ...
Clinical Validation of Plasma-Based Genotyping for RAS and BRAF V600E Mutation in Metastatic Colorectal Cancer: SCRUM-Japan GOZILA Substudy Patients with stage I-III CM with a clinical 31-GEP result ...
An expert explains how gene-expression profile testing can inform treatment decisions for patients with squamous cell carcinoma. Gene-expression profile (GEP) testing among patients with squamous cell ...
The MarketWatch News Department was not involved in the creation of this content. -- Sentinel lymph node (SLN) status alone is not sufficient as node negative patients still experience relapse and ...
Across primary sites, histological subtypes, and mitotic count categories, clinicopathological factors and gene-expression profile results were consistent for discriminating SLN positivity rates.
Benefit of perioperative chemotherapy in the patients with loco-regional recurrence of HR-positive HER2-negative breast cancer: A multi-institutional retrospective cohort study. Identification of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results